Insider Shareholders with Direct Ownership of Dyne Therapeutics, Inc. (DYN)
This section provides a comprehensive overview of the insiders with direct ownership of Dyne Therapeutics, Inc. (DYN). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Dyne Therapeutics, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
0 | 2,442,039 | 6,815,965 $231 Million | 10 |
Feb 20, 2024
Reduced 0.05%
|
|
Atlas Venture Opportunity Fund Ii, L.P.
> 10% Shareholder |
934,581 | 0 | 934,581 $31.6 Million | 1 |
Dec 12, 2022
Added 50.0%
|
Joshua T Brumm
CEO & President |
1,916,277 | 1,485,306 | 537,998 $18.2 Million | 41 |
Mar 11, 2024
Reduced 1.58%
|
Wildon Farwell
Chief Medical Officer |
190,819 | 47,597 | 143,222 $4.85 Million | 23 |
Aug 19, 2024
Reduced 0.18%
|
Oxana Beskrovnaya
Chief Scientific Officer |
268,668 | 147,582 | 140,375 $4.75 Million | 28 |
Sep 18, 2024
Reduced 1.64%
|
Jonathan Mc Neill
Chief Business Officer |
347,822 | 252,626 | 132,106 $4.47 Million | 39 |
Aug 19, 2024
Reduced 0.23%
|
Susanna Gatti High
Chief Operating Officer |
339,158 | 243,426 | 131,636 $4.45 Million | 31 |
Sep 18, 2024
Reduced 3.4%
|
Richard William Scalzo
SVP, Head of Finance & Admin. |
418,908 | 331,805 | 98,568 $3.33 Million | 40 |
Sep 18, 2024
Reduced 1.39%
|
Johanna Friedl Naderer
Chief Commercial Officer |
58,400 | 0 | 58,400 $1.98 Million | 1 |
Sep 03, 2024
Added 50.0%
|
Douglas Kerr
Chief Medical Officer |
47,500 | 0 | 47,500 $1.61 Million | 1 |
Sep 03, 2024
Added 50.0%
|
0 | 29,435 | 0 $0 | 1 |
N/A
|